Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
-
Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO' has been granted marketing approval in
Japan -
First marketing approval under the partnership with NIPRO CORPORATION, paving the way for expanding treatment option for patients in
Japan -
‘NIPRO’ will be commercially available following its listing on the
National Health Insurance (NHI) drug price list inMay 2026
INCHEON,
“Japan allocates about 10% of its GDP to healthcare2, one of the highest among
Ustekinumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that prevents abnormal regulation of IL-12 and IL-23 associated with immune-mediated diseases. ‘NIPRO’ has been approved for the treatment of plaque psoriasis, and psoriatic arthritis. The product is set to be listed in the Japan’s
Samsung Bioepis’s ustekinumab is also approved and available across
About
Established in 2012,
|
|
|
| 1 Stelara is a trademark of Johnson & Johnson. | |
| 2 OECD Health Statistics 2025. | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251222415902/en/
MEDIA CONTACT
Anna Nayun Kim, nayun86.kim@samsung.com
Source:


Reports Outline Investment Findings from Federal Reserve Board (Monetary Policy Shocks: Data or Methods?): Investment
Data on Managed Care Described by Researchers at Brigham and Women’s Hospital (The Next Frontier of Kidney Care Quality: Addressing Known Gaps to Transform Care Delivery): Managed Care
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
More Annuity NewsHealth/Employee Benefits News
- States push short-term insurance as healthcare costs climb
- WYDEN, SANDERS, SENATE DEMOCRATS CALL OUT INSURANCE COMPANY COLLUSION WITH TRUMP ADMINISTRATION TO KICK THOUSANDS OF AMERICANS OFF HEALTH INSURANCE
- WYDEN STATEMENT ON FINANCE COMMITTEE DEMOCRATIC MAJORITY AGENDA
- Health insurance switch costs city
- New LTC solutions fill a critical gap for clients
More Health/Employee Benefits NewsLife Insurance News
- AM Best Upgrades Credit Ratings of CTBC Insurance Company Ltd
- AM Best Affirms Credit Ratings of NongHyup Property and Casualty Insurance Company Limited
- AM Best Affirms Credit Ratings of Delphi Financial Group, Inc. and Its Subsidiaries; Upgrades Issuer Credit Rating of Standard Security Life Insurance Company of New York
- November Issue of Best’s Review Ranks US Life Reinsurers and More
- Nebraska widow’s big win against life insurer in legal limbo
More Life Insurance News